Correction: Anti-CD5 CAR-T cells with a tEGFR safety switch exhibit potent toxicity control

• Haolong Lin,
• Jiali Cheng,
• Li Zhu,
• Yuhao Zeng,
• Zhenyu Dai,
• Yicheng Zhang,
• Xiaojian Zhu,
• Wei Mu

Affiliations

Haolong Lin

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Jiali Cheng

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Li Zhu

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Yuhao Zeng

Department of Internal Medicine, Cleveland Clinic, Akron General

Zhenyu Dai

Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University

Yicheng Zhang

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Xiaojian Zhu

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wei Mu

Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology